Colchicine and Inflammation in Hemodialysis Patients
Condition: End Stage Renal Disease on Dialysis Interventions: Drug: Colchicine 0.5 MG; Drug: Placebo Sponsor: Assaf-Harofeh Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2023 Category: Research Source Type: clinical trials